Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$10.8M
19M shares
52-week range
$0.43 – $2.04
10% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.
www.bullfrogai.comNo one on the platform currently holds BFRG.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 12,000 | $20.2K |
No one on the platform has traded BFRG yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$BFRG did they get an extension or are they doing a reverse split?
View on StockTwits ↗$BFRG Posted 3hrs ago on Linkedin. https://www.linkedin.com/in/vinsingh/ Link referenced in post https://bullfrogai.com/technology/
View on StockTwits ↗$BFRG extension should be announced in next day or two, then PR regarding pilot with Pharma in next week or two id think. Looking good, excited to see what Pharma deal looks like with expansion, big things to come for. Bullfrog and a rerating of the stock price
View on StockTwits ↗$BFRG The Nasdaq $1 compliance period is until August 10, but there hasn’t been any announcement yet?
View on StockTwits ↗$BFRG Interesting DD. 👃👀 https://x.com/i/status/2086907965693395327
View on StockTwits ↗$BFRG This should be a $100+ stock. I'm still holding as I think this company has a big upside opportunigy, that said I would like an explanation as to why the CEO would get a 50% raise as the stock performance of this company has been terrible. I hope there is something that the board is aware of that justifies giving this type of raise.
View on StockTwits ↗$BFRG i took my massive fucking loss. fuck this stock im moving on from it
View on StockTwits ↗$BFRG There isn't any new SEC filing. You must be referring to the following SEC Form S-1 filed on May 29, 2026. https://ir.bullfrogai.com/sec-filings/all-sec-filings/content/0001493152-26-026390/0001493152-26-026390.pdf Relevant quotes: "This prospectus relates to the resale, from time to time, of up to 2,000,000 shares of our common stock, par value $0.00001 per share, by Lincoln Park Capital Fund, LLC." "Our common stock is listed on the Nasdaq Capital Market LLC (“Nasdaq”) under the symbol “BFRG”. The last reported sale price of our common stock on Nasdaq on May 28, 2026 was $0.72 per share."
View on StockTwits ↗$BFRG public offering of 2million shares for .72 cents! This is plummeting tomorrow and will see sun .50/.40 this month!
View on StockTwits ↗$BFRG Posted earlier today. https://www.linkedin.com/posts/bullfrogai-share-7490395003790471169-jgK1/?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAB8W4rEBBxhOUMJGLTgF6X_hZxjKb5mdh9Y&utm_campaign=copy_link
View on StockTwits ↗$BFRG Inversion... https://www.youtube.com/shorts/5stTTKQwAc4
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $350000 | — | $-0.44 | $-0.44–$-0.44 | — | 1 |
| 2027 | $5M | +1400.0% | $-0.21 | $-0.21–$-0.21 | — | 1 |
| 2028 | $16M | +195.2% | $0.02 | $0.02–$0.02 | 29.5× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| $2M |
| — |
| DWTXDogwood Therapeutics, Inc. | $1.98 | +2.86% | $67M | — |
| EDSAEdesa Biotech, Inc. | $5.43 | +2.45% | $52M | — |
Source: Financial Modeling Prep · peers by sector/industry